CD79A Gene Agammaglobulinemia Type 3 Autosomal Recessive NGS Genetic DNA Test
Introduction
The CD79A Gene Agammaglobulinemia Type 3 Autosomal Recessive NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the CD79A gene, which are associated with severe immunodeficiency disorders. This test plays a crucial role in understanding genetic immunodeficiencies, enabling healthcare providers to make informed decisions regarding patient management and treatment.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to detect specific mutations in the CD79A gene. By analyzing the genetic material, the test can identify whether an individual carries mutations that could lead to Agammaglobulinemia, a condition characterized by the absence of immunoglobulins and increased susceptibility to infections.
Who Should Consider This Test
Individuals who may benefit from the CD79A Gene Agammaglobulinemia Type 3 test include:
- Patients with recurrent infections or a family history of immunodeficiency disorders.
- Individuals presenting with symptoms such as chronic respiratory infections, autoimmune disorders, or failure to thrive.
- Family members of diagnosed patients seeking genetic counseling and risk assessment.
Benefits of Taking the Test
Taking the CD79A Gene Agammaglobulinemia Type 3 test offers several benefits:
- Accurate diagnosis of genetic immunodeficiencies.
- Informed family planning through genetic counseling.
- Personalized treatment strategies based on genetic insights.
- Improved understanding of potential health risks for family members.
Understanding Your Results
Once the test is completed, results will indicate whether mutations in the CD79A gene are present. A genetic counselor or healthcare provider will help interpret the results, discussing their implications for your health and any necessary follow-up actions.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| CD79A Gene Agammaglobulinemia Type 3 Autosomal Recessive NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Book Your Test Today
To schedule your CD79A Gene Agammaglobulinemia Type 3 Autosomal Recessive NGS Genetic DNA Test, please contact us at +2348077798758. Our dedicated team is here to assist you with the booking process and answer any questions you may have.
Turnaround time for results is approximately 3 to 4 weeks, and we accept samples of blood, extracted DNA, or one drop of blood on an FTA card. Prior to the test, a clinical history and genetic counseling session is recommended to draw a pedigree chart of family members affected by CD79A Gene Agammaglobulinemia.
Trust DNA Labs Nigeria for your genetic testing needs and take the first step towards understanding your health better.
